c-Kit triggers dual phosphorylations, which couple activation and degradation of the essential melanocyte factor Mi.

PubWeight™: 3.13‹?› | Rank: Top 1%

🔗 View Article (PMC 316361)

Published in Genes Dev on February 01, 2000

Authors

M Wu1, T J Hemesath, C M Takemoto, M A Horstmann, A G Wells, E R Price, D Z Fisher, D E Fisher

Author Affiliations

1: Division of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, USA.

Articles citing this

(truncated to the top 100)

ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol Mol Biol Rev (2004) 9.54

Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases. Microbiol Mol Biol Rev (2011) 5.02

Oncogenic BRAF regulates oxidative metabolism via PGC1α and MITF. Cancer Cell (2013) 3.63

The transcription factor TFEB links mTORC1 signaling to transcriptional control of lysosome homeostasis. Sci Signal (2012) 3.40

A melanocyte lineage program confers resistance to MAP kinase pathway inhibition. Nature (2013) 3.38

Melanoma: from mutations to medicine. Genes Dev (2012) 2.59

From genes to drugs: targeted strategies for melanoma. Nat Rev Cancer (2012) 2.46

Inhibiting Drivers of Non-mutational Drug Tolerance Is a Salvage Strategy for Targeted Melanoma Therapy. Cancer Cell (2016) 2.39

BMAL1-dependent circadian oscillation of nuclear CLOCK: posttranslational events induced by dimerization of transcriptional activators of the mammalian clock system. Genes Dev (2003) 2.37

Frequent mutations in the MITF pathway in melanoma. Pigment Cell Melanoma Res (2009) 2.27

Oncogenic BRAF regulates melanoma proliferation through the lineage specific factor MITF. PLoS One (2008) 2.15

MLANA/MART1 and SILV/PMEL17/GP100 are transcriptionally regulated by MITF in melanocytes and melanoma. Am J Pathol (2003) 1.90

Linking osteopetrosis and pycnodysostosis: regulation of cathepsin K expression by the microphthalmia transcription factor family. Proc Natl Acad Sci U S A (2001) 1.81

Microphthalmia transcription factor as a molecular marker for circulating tumor cell detection in blood of melanoma patients. Clin Cancer Res (2006) 1.72

MITF drives endolysosomal biogenesis and potentiates Wnt signaling in melanoma cells. Proc Natl Acad Sci U S A (2015) 1.68

Elevated expression of MITF counteracts B-RAF-stimulated melanocyte and melanoma cell proliferation. J Cell Biol (2005) 1.66

Regulation of MITF stability by the USP13 deubiquitinase. Nat Commun (2011) 1.62

Characterization of regulatory events associated with membrane targeting of p90 ribosomal S6 kinase 1. Mol Cell Biol (2001) 1.61

The other pigment cell: specification and development of the pigmented epithelium of the vertebrate eye. Pigment Cell Res (2006) 1.59

Enhancer-targeted genome editing selectively blocks innate resistance to oncokinase inhibition. Genome Res (2014) 1.49

Nrarp is a novel intracellular component of the Notch signaling pathway. Genes Dev (2001) 1.35

Retracted MicroRNA-340-mediated degradation of microphthalmia-associated transcription factor mRNA is inhibited by the coding region determinant-binding protein. J Biol Chem (2010) 1.32

The microphthalmia-associated transcription factor Mitf interacts with beta-catenin to determine target gene expression. Mol Cell Biol (2006) 1.31

p38 regulates pigmentation via proteasomal degradation of tyrosinase. J Biol Chem (2010) 1.28

Sumoylation modulates transcriptional activity of MITF in a promoter-specific manner. Pigment Cell Res (2005) 1.28

The Brn-2 transcription factor links activated BRAF to melanoma proliferation. Mol Cell Biol (2004) 1.24

The Usf-1 transcription factor is a novel target for the stress-responsive p38 kinase and mediates UV-induced Tyrosinase expression. EMBO J (2001) 1.23

MiTF regulates cellular response to reactive oxygen species through transcriptional regulation of APE-1/Ref-1. J Invest Dermatol (2008) 1.23

miR-148 regulates Mitf in melanoma cells. PLoS One (2010) 1.21

Acetylation and MAPK phosphorylation cooperate to regulate the degradation of active GATA-1. EMBO J (2006) 1.16

Melanocytes in development and cancer. J Cell Physiol (2010) 1.15

A RANKL-PKCβ-TFEB signaling cascade is necessary for lysosomal biogenesis in osteoclasts. Genes Dev (2013) 1.15

NRAS mutant melanoma: biological behavior and future strategies for therapeutic management. Oncogene (2012) 1.15

colgate/hdac1 Repression of foxd3 expression is required to permit mitfa-dependent melanogenesis. Dev Biol (2007) 1.14

Microphthalmia-associated transcription factor in melanoma development and MAP-kinase pathway targeted therapy. Pigment Cell Melanoma Res (2015) 1.12

Understanding signaling cascades in melanoma. Photochem Photobiol (2007) 1.10

MITF and cell proliferation: the role of alternative splice forms. Pigment Cell Res (2005) 1.10

The generation and characterization of a cell line derived from a sporadic renal angiomyolipoma: use of telomerase to obtain stable populations of cells from benign neoplasms. Am J Pathol (2001) 1.08

Regulation of the MiTF/TFE bHLH-LZ transcription factors through restricted spatial expression and alternative splicing of functional domains. Nucleic Acids Res (2004) 1.06

The roles of microphthalmia-associated transcription factor and pigmentation in melanoma. Arch Biochem Biophys (2014) 1.05

A genomic screen identifies TYRO3 as a MITF regulator in melanoma. Proc Natl Acad Sci U S A (2009) 1.04

The cleavage of microphthalmia-associated transcription factor, MITF, by caspases plays an essential role in melanocyte and melanoma cell apoptosis. Genes Dev (2005) 1.02

Molecular Network Associated with MITF in Skin Melanoma Development and Progression. J Skin Cancer (2011) 1.01

Recruitment of the extracellular signal-regulated kinase/ribosomal S6 kinase signaling pathway to the NFATc4 transcription activation complex. Mol Cell Biol (2005) 1.01

Interplay between MITF, PIAS3, and STAT3 in mast cells and melanocytes. Mol Cell Biol (2004) 1.00

KIT signaling regulates MITF expression through miRNAs in normal and malignant mast cell proliferation. Blood (2011) 0.99

The role of MITF phosphorylation sites during coat color and eye development in mice analyzed by bacterial artificial chromosome transgene rescue. Genetics (2009) 0.99

Mechanisms regulating skin pigmentation: the rise and fall of complexion coloration. Int J Mol Sci (2009) 0.98

The basic helix-loop-helix leucine zipper transcription factor Mitf is conserved in Drosophila and functions in eye development. Genetics (2004) 0.98

Arginylation-dependent regulation of a proteolytic product of talin is essential for cell-cell adhesion. J Cell Biol (2012) 0.98

MITF in melanoma: mechanisms behind its expression and activity. Cell Mol Life Sci (2014) 0.97

Mechanisms of cell-cycle arrest in Spitz nevi with constitutive activation of the MAP-kinase pathway. Am J Pathol (2004) 0.97

Characterization of an ERK-binding domain in microphthalmia-associated transcription factor and differential inhibition of ERK2-mediated substrate phosphorylation. J Biol Chem (2005) 0.96

The de-ubiquitinylating enzyme, USP2, is associated with the circadian clockwork and regulates its sensitivity to light. PLoS One (2011) 0.96

Mutations in the c-Kit gene disrupt mitogen-activated protein kinase signaling during tumor development in adenoid cystic carcinoma of the salivary glands. Neoplasia (2010) 0.95

{alpha}MSH and Cyclic AMP elevating agents control melanosome pH through a protein kinase A-independent mechanism. J Biol Chem (2009) 0.95

Role played by microphthalmia transcription factor phosphorylation and its Zip domain in its transcriptional inhibition by PIAS3. Mol Cell Biol (2003) 0.94

FOXP3 over-expression inhibits melanoma tumorigenesis via effects on proliferation and apoptosis. Oncotarget (2014) 0.93

Inhibition of melanogenesis by gallic acid: possible involvement of the PI3K/Akt, MEK/ERK and Wnt/β-catenin signaling pathways in B16F10 cells. Int J Mol Sci (2013) 0.92

The potential role of vitamin D in the progression of benign and malignant melanocytic neoplasms. Exp Dermatol (2010) 0.89

Beyond indigestion: emerging roles for lysosome-based signaling in human disease. Curr Opin Cell Biol (2015) 0.89

An unstable targeted allele of the mouse Mitf gene with a high somatic and germline reversion rate. Genetics (2008) 0.89

UV signaling pathways within the skin. J Invest Dermatol (2014) 0.88

A potent inhibitor of SIK2, 3, 3', 7-trihydroxy-4'-methoxyflavon (4'-O-methylfisetin), promotes melanogenesis in B16F10 melanoma cells. PLoS One (2011) 0.88

Genome-Wide DNA Methylation Analysis in Melanoma Reveals the Importance of CpG Methylation in MITF Regulation. J Invest Dermatol (2015) 0.88

Melanoma biology and the promise of zebrafish. Zebrafish (2008) 0.88

C-KIT signaling depends on microphthalmia-associated transcription factor for effects on cell proliferation. PLoS One (2011) 0.88

Networks and pathways in pigmentation, health, and disease. Wiley Interdiscip Rev Syst Biol Med (2010) 0.86

Antimelanogenic effect of c-phycocyanin through modulation of tyrosinase expression by upregulation of ERK and downregulation of p38 MAPK signaling pathways. J Biomed Sci (2011) 0.86

Understanding the biology of melanoma and therapeutic implications. Hematol Oncol Clin North Am (2014) 0.85

The Complexity of the ERK/MAP-Kinase Pathway and the Treatment of Melanoma Skin Cancer. Front Cell Dev Biol (2016) 0.83

In vivo role of alternative splicing and serine phosphorylation of the microphthalmia-associated transcription factor. Genetics (2012) 0.83

Hesperidin, A Popular Antioxidant Inhibits Melanogenesis via Erk1/2 Mediated MITF Degradation. Int J Mol Sci (2015) 0.83

[6]-Shogaol inhibits α-MSH-induced melanogenesis through the acceleration of ERK and PI3K/Akt-mediated MITF degradation. Biomed Res Int (2014) 0.83

The 19S proteasomal lid subunit POH1 enhances the transcriptional activation by Mitf in osteoclasts. J Cell Biochem (2010) 0.83

The melanocyte inducing factor MITF is stably expressed in cell lines from human clear cell sarcoma. Br J Cancer (2003) 0.82

[6]-Shogaol inhibits melanogenesis in B16 mouse melanoma cells through activation of the ERK pathway. Acta Pharmacol Sin (2012) 0.82

Involvement of mTOR signaling in sphingosylphosphorylcholine-induced hypopigmentation effects. J Biomed Sci (2011) 0.82

Tranexamic Acid Diminishes Laser-Induced Melanogenesis. Ann Dermatol (2015) 0.82

MicroRNA-340-mediated degradation of microphthalmia-associated transcription factor (MITF) mRNA is inhibited by coding region determinant-binding protein (CRD-BP). J Biol Chem (2014) 0.82

The lysosome as a command-and-control center for cellular metabolism. J Cell Biol (2016) 0.81

Glyceollins, a novel class of soybean phytoalexins, inhibit SCF-induced melanogenesis through attenuation of SCF/c-kit downstream signaling pathways. Exp Mol Med (2013) 0.81

Hearing dysfunction in heterozygous Mitf(Mi-wh) /+ mice, a model for Waardenburg syndrome type 2 and Tietz syndrome. Pigment Cell Melanoma Res (2012) 0.81

Supercritical Fluid Extract of Spent Coffee Grounds Attenuates Melanogenesis through Downregulation of the PKA, PI3K/Akt, and MAPK Signaling Pathways. Evid Based Complement Alternat Med (2016) 0.81

MiTF links Erk1/2 kinase and p21 CIP1/WAF1 activation after UVC radiation in normal human melanocytes and melanoma cells. Mol Cancer (2010) 0.80

Role of BMP-4 and Its Signaling Pathways in Cultured Human Melanocytes. Int J Cell Biol (2009) 0.80

The potential of minor ginsenosides isolated from the leaves of Panax ginseng as inhibitors of melanogenesis. Int J Mol Sci (2015) 0.79

Evidence for an alternatively spliced MITF exon 2 variant. J Invest Dermatol (2013) 0.79

Norartocarpetin from a folk medicine Artocarpus communis plays a melanogenesis inhibitor without cytotoxicity in B16F10 cell and skin irritation in mice. BMC Complement Altern Med (2013) 0.79

Allelic Mutations of KITLG, Encoding KIT Ligand, Cause Asymmetric and Unilateral Hearing Loss and Waardenburg Syndrome Type 2. Am J Hum Genet (2015) 0.78

Conditioned Media from Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Inhibits Melanogenesis by Promoting Proteasomal Degradation of MITF. PLoS One (2015) 0.78

Hematopoietic- and neurologic-expressed sequence 1 (Hn1) depletion in B16.F10 melanoma cells promotes a differentiated phenotype that includes increased melanogenesis and cell cycle arrest. Differentiation (2009) 0.78

Extracts of Artocarpus communis decrease α-melanocyte stimulating hormone-induced melanogenesis through activation of ERK and JNK signaling pathways. ScientificWorldJournal (2014) 0.78

ERK Activation by Fucoidan Leads to Inhibition of Melanogenesis in Mel-Ab Cells. Korean J Physiol Pharmacol (2014) 0.78

The master role of microphthalmia-associated transcription factor in melanocyte and melanoma biology. Lab Invest (2017) 0.78

Melanogenesis inhibitory effect of aerial part of Pueraria thunbergiana in vitro and in vivo. Arch Dermatol Res (2014) 0.77

Lebein, a Snake Venom Disintegrin, Induces Apoptosis in Human Melanoma Cells. Toxins (Basel) (2016) 0.77

PLX4032 Mediated Melanoma Associated Antigen Potentiation in Patient Derived Primary Melanoma Cells. J Cancer (2015) 0.77

The effects of Caffeoylserotonin on inhibition of melanogenesis through the downregulation of MITF via the reduction of intracellular cAMP and acceleration of ERK activation in B16 murine melanoma cells. BMB Rep (2012) 0.76

STAP-2 Protein Expression in B16F10 Melanoma Cells Positively Regulates Protein Levels of Tyrosinase, Which Determines Organs to Infiltrate in the Body. J Biol Chem (2015) 0.76

Articles cited by this

pEF-BOS, a powerful mammalian expression vector. Nucleic Acids Res (1990) 12.75

The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B. Cell (1994) 11.62

A multiubiquitin chain is confined to specific lysine in a targeted short-lived protein. Science (1989) 9.68

The ubiquitin system for protein degradation. Annu Rev Biochem (1992) 8.84

Insulin-stimulated MAP-2 kinase phosphorylates and activates ribosomal protein S6 kinase II. Nature (1988) 7.82

Hereditary anemias of the mouse: a review for geneticists. Adv Genet (1979) 6.91

Signal transduction via the MAP kinases: proceed at your own RSK. Proc Natl Acad Sci U S A (1993) 6.19

Functions of the proteasome: the lysis at the end of the tunnel. Science (1995) 5.29

Identification of a ligand for the c-kit proto-oncogene. Cell (1990) 4.04

MAP kinase links the transcription factor Microphthalmia to c-Kit signalling in melanocytes. Nature (1998) 3.53

microphthalmia, a critical factor in melanocyte development, defines a discrete transcription factor family. Genes Dev (1994) 3.44

Identification of regulatory phosphorylation sites in mitogen-activated protein kinase (MAPK)-activated protein kinase-1a/p90rsk that are inducible by MAPK. J Biol Chem (1998) 3.29

p300/MDM2 complexes participate in MDM2-mediated p53 degradation. Mol Cell (1998) 3.27

Proteolysis, proteasomes and antigen presentation. Nature (1992) 3.15

Waardenburg syndrome type 2 caused by mutations in the human microphthalmia (MITF) gene. Nat Genet (1994) 2.99

Proteasome-dependent degradation of the human estrogen receptor. Proc Natl Acad Sci U S A (1999) 2.81

Regulation of interferon-gamma-activated STAT1 by the ubiquitin-proteasome pathway. Science (1996) 2.66

Role of general and gene-specific cofactors in the regulation of eukaryotic transcription. Cold Spring Harb Symp Quant Biol (1998) 2.54

Chromatin-modifying and -remodeling complexes. Curr Opin Genet Dev (1999) 2.51

Steel locus defines new multipotent growth factor. Cell (1990) 2.31

Melanocyte-specific expression of the human tyrosinase promoter: activation by the microphthalmia gene product and role of the initiator. Mol Cell Biol (1994) 2.24

Microphthalmia gene product as a signal transducer in cAMP-induced differentiation of melanocytes. J Cell Biol (1998) 2.20

Comparison of the specificities of p70 S6 kinase and MAPKAP kinase-1 identifies a relatively specific substrate for p70 S6 kinase: the N-terminal kinase domain of MAPKAP kinase-1 is essential for peptide phosphorylation. FEBS Lett (1995) 2.19

Microphthalmia-associated transcription factor as a regulator for melanocyte-specific transcription of the human tyrosinase gene. Mol Cell Biol (1994) 2.13

A MAP kinase docking site is required for phosphorylation and activation of p90(rsk)/MAPKAP kinase-1. Curr Biol (1999) 1.94

IkappaB alpha is a target for the mitogen-activated 90 kDa ribosomal S6 kinase. EMBO J (1997) 1.91

Microphthalmia transcription factor. A sensitive and specific melanocyte marker for MelanomaDiagnosis. Am J Pathol (1999) 1.80

Different cis-acting elements are involved in the regulation of TRP1 and TRP2 promoter activities by cyclic AMP: pivotal role of M boxes (GTCATGTGCT) and of microphthalmia. Mol Cell Biol (1998) 1.62

Aberrant retention of tyrosinase in the endoplasmic reticulum mediates accelerated degradation of the enzyme and contributes to the dedifferentiated phenotype of amelanotic melanoma cells. Proc Natl Acad Sci U S A (1997) 1.61

Regulation of tyrosinase gene expression by cAMP in B16 melanoma cells involves two CATGTG motifs surrounding the TATA box: implication of the microphthalmia gene product. J Cell Biol (1996) 1.57

Phosphorylation of c-Fos at the C-terminus enhances its transforming activity. Oncogene (1996) 1.56

The 90-kDa ribosomal S6 kinase (pp90rsk) phosphorylates the N-terminal regulatory domain of IkappaBalpha and stimulates its degradation in vitro. J Biol Chem (1997) 1.53

Regulation of an epitope-tagged recombinant Rsk-1 S6 kinase by phorbol ester and erk/MAP kinase. Biochemistry (1993) 1.50

Lineage-specific signaling in melanocytes. C-kit stimulation recruits p300/CBP to microphthalmia. J Biol Chem (1998) 1.47

Insight into the microphthalmia gene. Trends Genet (1995) 1.46

A gene for Waardenburg syndrome type 2 maps close to the human homologue of the microphthalmia gene at chromosome 3p12-p14.1. Nat Genet (1994) 1.44

Inhibition of the mitogen-activated protein kinase pathway triggers B16 melanoma cell differentiation. J Biol Chem (1998) 1.40

Age-resolving osteopetrosis: a rat model implicating microphthalmia and the related transcription factor TFE3. J Exp Med (1998) 1.35

alpha-Melanocyte-stimulating hormone signaling regulates expression of microphthalmia, a gene deficient in Waardenburg syndrome. J Biol Chem (1998) 1.34

CBP/p300 as a co-factor for the Microphthalmia transcription factor. Oncogene (1997) 1.31

KIT ligand (mast cell growth factor) inhibits the growth of KIT-expressing melanoma cells. Oncogene (1993) 1.30

Activation of RNA polymerase II transcription. Curr Opin Cell Biol (1999) 1.29

Recombinant human stem cell factor (kit ligand) promotes human mast cell and melanocyte hyperplasia and functional activation in vivo. J Exp Med (1996) 1.27

Transcription of chromatin: these are complex times. Curr Opin Genet Dev (1998) 1.26

Cloning of MITF, the human homolog of the mouse microphthalmia gene and assignment to chromosome 3p14.1-p12.3. Hum Mol Genet (1994) 1.23

Ubiquitin metabolism in cycling Xenopus egg extracts. J Biol Chem (1993) 1.22

Stem cell factor as a survival and growth factor in human normal and malignant hematopoiesis. Acta Haematol (1996) 1.20

A mouse model for vitiligo. J Invest Dermatol (1986) 1.19

Activation of MAP kinases, pp90rsk and pp70-S6 kinases in mouse mast cells by signaling through the c-kit receptor tyrosine kinase or Fc epsilon RI: rapamycin inhibits activation of pp70-S6 kinase and proliferation in mouse mast cells. Eur J Immunol (1993) 1.19

Involvement of transcription factor encoded by the mi locus in the expression of c-kit receptor tyrosine kinase in cultured mast cells of mice. Blood (1996) 1.16

Nerve growth factor-induced phosphorylation cascade in PC12 pheochromocytoma cells. Association of S6 kinase II with the microtubule-associated protein kinase, ERK1. J Biol Chem (1992) 1.11

Gene transcription by recruitment. Cold Spring Harb Symp Quant Biol (1998) 1.10

Tyrosinase, melan-A, and KBA62 as markers for the immunohistochemical identification of metastatic amelanotic melanomas on paraffin sections. Mod Pathol (1998) 1.07

The c-fms gene complements the mitogenic defect in mast cells derived from mutant W mice but not mi (microphthalmia) mice. Proc Natl Acad Sci U S A (1991) 0.93

Cytoplasmic to nuclear signal transduction by mitogen-activated protein kinase and 90 kDa ribosomal S6 kinase. Biochem Soc Trans (1993) 0.92

Melanoma-associated antigens. Eur J Cancer (1993) 0.88

Evidence to suggest that expression of MITF induces melanocyte differentiation and haploinsufficiency of MITF causes Waardenburg syndrome type 2A. Pigment Cell Res (1997) 0.83

Stimulation of hematopoiesis in vivo by stem cell factor. Curr Opin Hematol (1994) 0.80

C-kit receptors in childhood malignant lymphoblastic cells. Leuk Lymphoma (1997) 0.79

Articles by these authors

p53 status and the efficacy of cancer therapy in vivo. Science (1994) 6.72

Radiation hybrid mapping: a somatic cell genetic method for constructing high-resolution maps of mammalian chromosomes. Science (1990) 5.35

cDNA sequencing of nuclear lamins A and C reveals primary and secondary structural homology to intermediate filament proteins. Proc Natl Acad Sci U S A (1986) 5.07

MAP kinase links the transcription factor Microphthalmia to c-Kit signalling in melanocytes. Nature (1998) 3.53

microphthalmia, a critical factor in melanocyte development, defines a discrete transcription factor family. Genes Dev (1994) 3.44

Role of kinases and the phosphatase calcineurin in the nuclear shuttling of transcription factor NF-AT4. Nature (1996) 3.41

Small nuclear ribonucleoprotein particle assembly in vivo: demonstration of a 6S RNA-free core precursor and posttranslational modification. Cell (1985) 2.36

Microphthalmia gene product as a signal transducer in cAMP-induced differentiation of melanocytes. J Cell Biol (1998) 2.20

Idiotype-like molecules on cells of a human T cell leukemia. J Exp Med (1983) 2.19

Regulation of proliferation-survival decisions during tumor cell hypoxia. Mol Cell Biol (1998) 2.11

Percutaneous central venous catheterization. Three years' experience in a neonatal intensive care unit. Am J Dis Child (1990) 1.85

atm and p53 cooperate in apoptosis and suppression of tumorigenesis, but not in resistance to acute radiation toxicity. Nat Genet (1997) 1.85

Linking osteopetrosis and pycnodysostosis: regulation of cathepsin K expression by the microphthalmia transcription factor family. Proc Natl Acad Sci U S A (2001) 1.81

Microphthalmia transcription factor. A sensitive and specific melanocyte marker for MelanomaDiagnosis. Am J Pathol (1999) 1.80

Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. I. Epidemiologic rationale. J Infect Dis (1983) 1.78

Pre-bending of a promoter sequence enhances affinity for the TATA-binding factor. Nature (1995) 1.74

Synthesis and assembly of human small nuclear ribonucleoproteins generated by cell-free translation. Proc Natl Acad Sci U S A (1983) 1.68

Corticosteroid-induced avascular necrosis. A clinical study of seventy-seven patients. J Bone Joint Surg Am (1971) 1.64

A map of the distal region of the long arm of human chromosome 21 constructed by radiation hybrid mapping and pulsed-field gel electrophoresis. Genomics (1991) 1.55

A CD44 survival pathway triggers chemoresistance via lyn kinase and phosphoinositide 3-kinase/Akt in colon carcinoma cells. Cancer Res (2001) 1.53

Lineage-specific signaling in melanocytes. C-kit stimulation recruits p300/CBP to microphthalmia. J Biol Chem (1998) 1.47

Linkage of M-CSF signaling to Mitf, TFE3, and the osteoclast defect in Mitf(mi/mi) mice. Mol Cell (2001) 1.45

Ser298 of MITF, a mutation site in Waardenburg syndrome type 2, is a phosphorylation site with functional significance. Hum Mol Genet (2000) 1.44

Loss of matrix adhesion triggers rapid transformation-selective apoptosis in fibroblasts. J Cell Biol (1997) 1.38

Age-resolving osteopetrosis: a rat model implicating microphthalmia and the related transcription factor TFE3. J Exp Med (1998) 1.35

Histologic demonstration of fat emboli in aseptic necrosis associated with hypercortisonism. Mayo Clin Proc (1969) 1.34

alpha-Melanocyte-stimulating hormone signaling regulates expression of microphthalmia, a gene deficient in Waardenburg syndrome. J Biol Chem (1998) 1.34

Isolation of mouse stromal cells associated with a human tumor using differential diphtheria toxin sensitivity. Am J Pathol (1999) 1.33

The latch region of calcineurin B is involved in both immunosuppressant-immunophilin complex docking and phosphatase activation. Cell (1994) 1.32

Direct evidence for the existence of nominal antigen binding sites on T cell surface Ti alpha-beta heterodimers of MHC-restricted T cell clones. Cell (1986) 1.32

Modulation of microphthalmia-associated transcription factor gene expression alters skin pigmentation. J Invest Dermatol (2002) 1.25

Cooperative study group for childhood acute lymphoblastic leukaemia (COALL): long-term results of trials 82,85,89,92 and 97. Leukemia (2009) 1.25

Apoptosis and cancer drug targeting. J Clin Invest (1999) 1.22

Microphthalmia transcription factor expression in cutaneous benign, malignant melanocytic, and nonmelanocytic tumors. Am J Surg Pathol (2001) 1.10

Psoriasis and Raynaud's phenomenon associated with autoantibodies to U1 and U2 small nuclear ribonucleoproteins. N Engl J Med (1986) 1.10

The role of fat embolism in the etiology of corticosteroid-induced avascular necrosis: clinical and experimental results. Clin Orthop Relat Res (1978) 1.09

The generation and characterization of a cell line derived from a sporadic renal angiomyolipoma: use of telomerase to obtain stable populations of cells from benign neoplasms. Am J Pathol (2001) 1.08

Essential role for caspase-8 in transcription-independent apoptosis triggered by p53. J Biol Chem (2000) 1.07

Genetic interactions between atm and p53 influence cellular proliferation and irradiation-induced cell cycle checkpoints. Cancer Res (1997) 1.07

The semidominant Mi(b) mutation identifies a role for the HLH domain in DNA binding in addition to its role in protein dimerization. EMBO J (1996) 1.04

Pulse labeling of small nuclear ribonucleoproteins in vivo reveals distinct patterns of antigen recognition by human autoimmune antibodies. Proc Natl Acad Sci U S A (1984) 1.04

Sensorineural deafness and pigmentation genes: melanocytes and the Mitf transcriptional network. Neuron (2001) 1.00

Temporal shifts from Sm to ribonucleoprotein reactivity in systemic lupus erythematosus. Arthritis Rheum (1985) 0.99

Autoimmune sera reactive with Sm antigen contain high levels of RNP-like antibodies. J Clin Invest (1985) 0.99

Hemangioendothelioma of the leg following metallic fixation of the tibia. Cancer (1972) 0.98

p53 in life and death. Clin Cancer Res (1996) 0.98

T cell antiidiotypic antibodies reveal differences between two human leukemias. J Exp Med (1984) 0.97

Involvement of microphthalmia in the inhibition of melanocyte lineage differentiation and of melanogenesis by agouti signal protein. J Biol Chem (1998) 0.95

The complete cDNA sequence of human hexabrachion (Tenascin). A multidomain protein containing unique epidermal growth factor repeats. J Biol Chem (1991) 0.94

Oncogene-dependent regulation of caspase activation by p53 protein in a cell-free system. J Biol Chem (1998) 0.93

Mechanisms of apoptotic cell death. Leukemia (1997) 0.93

Mechanisms of p53-mediated apoptosis. Crit Rev Oncog (1998) 0.92

Extensive apoptosis in ductal carcinoma in situ of the breast. Cancer (1996) 0.91

The leucine zipper may induce electrophoretic mobility anomalies without DNA bending. Proc Natl Acad Sci U S A (1996) 0.91

Apoptosis in tumorigenesis and cancer therapy. Front Biosci (1997) 0.91

Improved oxygenation with prone positioning in neonates: stability of increased transcutaneous PO2. J Perinatol (1991) 0.90

p53 and cancer therapy: a double-edged sword. J Clin Invest (1999) 0.90

Corticosteroid-induced aseptic necrosis. II. Experimental study. Clin Orthop Relat Res (1972) 0.89

Microphthalmia transcription factor: not a sensitive or specific marker for the diagnosis of desmoplastic melanoma and spindle cell (non-desmoplastic) melanoma. Am J Dermatopathol (2001) 0.88

"Lineage addiction" in human cancer: lessons from integrated genomics. Cold Spring Harb Symp Quant Biol (2005) 0.88

Cutis laxa, skeletal anomalies, and ambiguous genitalia. Am J Dis Child (1974) 0.87

DNA bending and the curious case of Fos/Jun. Chem Biol (1998) 0.87

Clear cell sarcoma shows immunoreactivity for microphthalmia transcription factor: further evidence for melanocytic differentiation. Mod Pathol (2001) 0.87

Microphthalmia transcription factor: a sensitive and specific marker for malignant melanoma in cytologic specimens. Cancer (2001) 0.86

Epidemiologic study of human tularemia reported in Missouri, 1949-65. Public Health Rep (1967) 0.85

Dapsone or electric shock therapy of brown recluse spider envenomation? Ann Emerg Med (1994) 0.84

Uptake and release of energy substrates, oxygen, and carbon dioxide by the hindlimb of the fasting infant baboon. Biol Neonate (1981) 0.84

Effect of a large deletion of the basic domain of mi transcription factor on differentiation of mast cells. Blood (2001) 0.84

Murine chromosomal location of five bHLH-Zip transcription factor genes. Genomics (1995) 0.82

Assessment of potentially avoidable perinatal mortality in a regionalized program. J Reprod Med (1990) 0.82

Precursors to glycogen in ovine fetuses. Am J Physiol (1988) 0.82

Key targets for the execution of radiation-induced tumor cell apoptosis: the role of p53 and caspases. Int J Radiat Oncol Biol Phys (2001) 0.81

A model for the prospective analysis of perinatal deaths in a perinatal network. Am J Obstet Gynecol (1990) 0.81

p53, caspase 8, and regulation of apoptosis after ionizing radiation. J Pediatr Hematol Oncol (2001) 0.79

Apoptosis and the prognostic significance of p53 mutation. Cold Spring Harb Symp Quant Biol (1994) 0.79

Corticosteroid-induced aseptic necrosis. Surg Forum (1969) 0.79

Regulation of melanocyte differentiation and growth. Cell Growth Differ (1997) 0.79

p53: from molecular mechanisms to prognosis in cancer. J Clin Oncol (1995) 0.78

The effect of initial Apgar score on the birthweight-specific survival of the very low-birthweight infant. Am J Perinatol (1987) 0.78

Adenovirus-mediated expression of a truncated PDGFbeta receptor inhibits thrombosis and neointima formation in an avian arterial injury model. Thromb Haemost (2001) 0.78

Identification of novel NOTCH1 mutations: increasing our knowledge of the NOTCH signaling pathway. Pediatr Blood Cancer (2013) 0.78

Gene transfer of SHIP-1 inhibits proliferation of juvenile myelomonocytic leukemia cells carrying KRAS2 or PTPN11 mutations. Gene Ther (2007) 0.78

Distinct mathematical behavior of apoptotic versus non-apoptotic tumor cell death. Int J Radiat Oncol Biol Phys (1999) 0.78

Celiac plexus blockade for a 3-year-old boy with hepatoblastoma and refractory pain. Pediatrics (1990) 0.77

Anatomy of the pulpal canal: three-dimensional visualization. J Endod (1975) 0.77